Comparison

Phospho-Jak2 (pY1007/1008)

Item no. 20-203-420123
Manufacturer GENWAY
Amount 0,1 ml
Category
Type Antibody
Applications WB, IP, IHC, ICC
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-7062C6
Similar products 20-203-420123
Available
Genway ID:
GWB-7062C6
Clone ID:
E132
Immunogen:
A synthetic phospho-peptide corresponding to residues surrounding Tyr1007 and Tyr1008 of human JAK2 was used as immunogen. The antibody only detects JAK2 phosphorylated on Tyrosine 1007 and 1008.
Specificity:
A synthetic phospho-peptide corresponding to residues surrounding Tyr1007 and Tyr1008 of human JAK2 was used as immunogen. The antibody only detects JAK2 phosphorylated on Tyrosine 1007 and 1008.
Dilution:
WB: 1:5 000-10 000IHC: 1:50-100ICC: 1:50-100IP: 1:50. Jak2 is a member of the Janus family tyrosine kinases (Jaks) whose function is to transduce extracellular signals from cytokines and interferons. Jaks associate with cytokine receptors; upon ligand binding Jaks phosphorylate the receptor. The phosphorylated receptors are bound by SH2-containing proteins one class of which is the signal transducers and activators of transcription (STATs). Activated STATs then translocate to the nucleus to mediate gene transcription (1 2). Tyr1007/1008 of Jak2 are the homologous Tyr1054/1055 in Tyk2 and phosphorylation at these residues is needed for Tyk2 activation (3). A chromosomal aberration involving Jak2 is found in a form of pre-B acute myeloid leukemia (4). 1. Leonard W. J. and J. J. O2. O\' Shea J. J. et al. Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency. J Clin Immunol. 17: 4313. Gauzzi M. C. et al. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J. Biol. Chem. 271: 204944. Peeters P. et al. Fusion of TEL the ETS-variant gene 6 (ETV6) to the receptor-associated kinase JAK2 as a result of t(9; 12) in a lymphoid and t(9; 15; 12) in a myeloid leukemia. Blood 90: 25355. Manufactured under U. S. Patents No. 5 675 063 and 7 429 487

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0,1 ml
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close